[一季报]东方精工(002611):2023年第一季度报告(英文)
|
时间:2023年04月22日 07:47:08 中财网 |
|
原标题:东方精工:2023年第一季度报告(英文)
GUANGDONG DONGFANG PRECISION SCIENCE & TECHNOLOGY CO., LTD. THE REPORT FOR THE FIRST QUARTER OF 2023
The Company as well as all members of the Board of Directors hereby guarantee the
factuality, accuracy, and completeness of the information disclosed, and its free of any
misrepresentations, misleading statements, or material omissions.
Important Notes:
1. The Board of Directors (or the “Board”), the Supervisory Committee as well as the directors, supervisors and senior management of Guangdong Dongfang Precision Science & Technology Co., Ltd. (hereinafter referred to as the “Company”) hereby guarantee the factuality, accuracy, and completeness of the
contents of this Report, and shall be jointly and severally liable for any misrepresentations, misleading
statements, or material omissions therein.
2. The Company’s legal representative, the Company’s Chief Financial Officer, and the person-in-charge
of the accounting organ hereby guarantee that the financial statements carried in this Report are factual,
accurate and complete.
st
3. Whether the 1 quarter report has been audited
□ Yes √ No
st
The report for the 1 quarter of 2023 of the Company has been prepared and released in Chinese, and now has been translated into English. Should there be any discrepancies or misunderstandings between the two versions, the Chinese version shall prevail. I Key Financial Information
1. Key Financial Data and Indicators
Indicate whether there is any retrospectively restated datum in the table below. □ Yes √ No
| Q1 2023 | Q1 2022 | Rate of Change | Operating revenue (RMB) | 907,101,141.80 | 636,006,580.11 | 42.62% | Net profit attributable to the listed company’s
shareholders (RMB yuan) | 84,973,342.92 | 37,109,411.15 | 128.98% | Net profit attributable to the listed company’s
shareholders before exceptional gains and
losses (RMB yuan) | 51,961,918.89 | 45,662,017.31 | 13.80% | Net cash generated from/used in operating
activities (RMB yuan) | 104,429,591.30 | 85,523,348.92 | 22.11% | Basic earnings per share (RMB / share) | 0.07 | 0.03 | 133.33% | Diluted earnings per share (RMB /share) | 0.07 | 0.03 | 133.33% | Weighted average return on equity (ROE) | 2.08% | 1.02% | 1.06% | | Ending balance
Of the Reporting Period | Beginning balance
Of the Reporting Period | Rate of Change | Total assets (RMB) | 7,127,787,958.35 | 6,928,577,115.10 | 2.88% | Equity attributable to the listed company’s
shareholders (RMB) | 4,096,865,613.57 | 4,063,966,310.23 | 0.81% |
2. Non-recurring profit and loss items and amount
√ Applicable □ Not applicable
Unit: RMB
Item | Q1 2023 | Notes | Gain or loss on disposal of non-current assets (inclusive of
impairment allowance write-offs) | -382,067.42 | | Government subsidies included in current profit or loss (exclusive
of government grants given in the Company’s ordinary course of
business at fixed quotas or amounts as per the government’s
uniform standards) | 2,550,704.06 | | Gain or loss on fair-value changes on held-for-trading and
derivative financial assets and liabilities & income from disposal
of held-for-trading and derivative financial assets and liabilities
and other debt investments (exclusive of the effective portion of
hedges that arise in the Company’s ordinary course of business) | 32,150,522.32 | | Non-Operating Revenue and expenses other than the above | -6,857.27 | | Less: Income tax effects | 229,557.37 | | Non-controlling interests effects (net of tax) | 1,071,320.29 | | Total | 33,011,424.03 | -- |
Other items that meet the definition of non-recurring profit and loss: □ Applicable √ Not applicable
No such cases for the Reporting Period.
Note of the reclassification of non-recurring items of profit or loss listed in "Explanatory Announcement No. 1 on Disclosure of
Information by Companies Issuing Public Securities - Non-recurring Profit or Loss" as recurring items of profit or loss:
□ Applicable √ Not applicable
No such cases for the Reporting Period.
3. Changes in Key Financial Data and Indicators and the Reasons √Applicable □ Not applicable
Unit: RMB
(1) Balance sheet items
Items | Ending balance
Of the Reporting Period | Beginning balance
Of the Reporting Period | Amount of Change | Rate of Change | Notes | Cash and bank balances | 1,429,733,808.80 | 1,274,447,199.74 | 155,286,609.06 | 12.18% | Mainly due to the increase of amount received for sales
and the redemption of some entrusted wealth management
products during the reporting period. | Financial assets held for
trading | 826,564,639.52 | 860,832,278.88 | -34,267,639.36 | -3.98% | Mainly due to the redemption of some entrusted wealth
management products during the reporting period. | Accounts receivable | 765,635,440.37 | 837,305,757.46 | -71,670,317.09 | -8.56% | Mainly due to the increase of amount received for sales in
the reporting period. | Other receivables | 38,754,459.26 | 83,996,902.82 | -45,242,443.56 | -53.86% | Mainly due to the early recovery of the remaining balance
of the transfer of equity interest of the Ferretto Group
during the reporting period. | Inventories | 1,241,618,636.81 | 1,092,981,884.51 | 148,636,752.30 | 13.60% | Mainly due to the increase in orders and the increase in
inventories during the reporting period. | Construction in progress | 71,640,546.10 | 38,904,537.85 | 32,736,008.25 | 84.14% | Mainly due to the investment in the construction of plants
during the reporting period. | Short-term borrowings | 96,301,680.12 | 41,815,129.24 | 54,486,550.88 | 130.30% | Mainly due to the increase in borrowings during the
reporting period. | Accounts payable | 703,414,660.38 | 748,319,561.21 | -44,904,900.83 | -6.00% | Mainly due to the payment for goods during the reporting
period. | Contract liabilities | 825,114,775.47 | 692,567,968.60 | 132,546,806.87 | 19.14% | Mainly due to the increase in orders during the reporting
period. | Treasury stock | 309,451,578.83 | 240,255,502.45 | 69,196,076.38 | 28.80% | Mainly due to share repurchase during the reporting
period. |
(2) Income statement items
Items | Q1 2023 | Q1 2022 | Amount of Change | Rate of Change | Notes | Operating revenue | 907,101,141.80 | 636,006,580.11 | 271,094,561.69 | 42.62% | Mainly due to the increase in sales during the reporting
period. | Cost of sales | 653,454,327.84 | 472,346,527.10 | 181,107,800.74 | 38.34% | Mainly due to the increase in sales for the reporting period. | Selling expenses | 49,395,917.66 | 24,373,541.29 | 25,022,376.37 | 102.66% | Mainly due to the increase in sales during the reporting
period. | R&D expenses | 27,637,218.09 | 18,824,950.19 | 8,812,267.90 | 46.81% | Mainly due to increased investment in research and
development during the reporting period. | Finance costs | 4,922,184.62 | -5,516,912.35 | 10,439,096.97 | 189.22% | Mainly due to changes in exchange rates during the
reporting period. | Investment income | 11,843,626.19 | -4,249,447.63 | 16,093,073.82 | 378.71% | Mainly due to the increase in investment income
recognized from the implementation of investments in
securities during the reporting period. | Gain/loss on changes in fair
value | 18,689,791.21 | -8,257,489.80 | 26,947,281.01 | 326.34% | Mainly due to the increase in fair value changes
recognized on the implementation of investments in
securities during the reporting period. |
(3) Cash flow statement items
Items | Q1 2023 | Q1 2022 | Amount of Change | Rate of Change | Notes | Net cash generated from/used
in operating activities | 104,429,591.30 | 85,523,348.92 | 18,906,242.38 | 22.11% | Mainly due to the increase in sales returns for the period. | Net cash generated from/used
in investing activities | 72,757,007.84 | -2,853,044.36 | 75,610,052.20 | 2650.15% | Mainly due to investment in subsidiaries in the same
period last year, which did not occur in the current period. | Net cash generated from/used
in financing activities | -42,170,254.94 | 19,572,369.24 | -61,742,624.18 | -315.46% | Mainly due to the recovery of loan deposits in the
previous year, which did not occur in the current period. |
II Shareholder Information
1. Total Number of Ordinary Shareholders and Number of Preference Shareholders with Resumed Voting Rights, as well as Information of Top 10 Shareholders
Unit: shares
Number of ordinary shareholders at
the period-end | 59,477 | Number of preference
shareholders with resumed
voting rights at the period-end
(if any) | Not applicable | | | | Top 10 shareholders | | | | | | | Name of
shareholder | Nature of
shareholder | Shareholding
percentage | Total shares held
at the period-end | Restricted shares
held | Shares in pledge or frozen | | | | | | | Status | Shares | Tang Zhuolin | Domestic
individual | 21.82% | 270,737,568 | 203,053,176 | In pledge | 105,360,000 | Tang Zhuomian | Domestic
individual | 7.81% | 96,885,134 | 0 | In pledge | 40,000,000 | Pulead Technology
Industry Co., Ltd. | State-owned
corporation | 3.88% | 48,149,787 | 0 | | | Luzhou Industrial
Development
Investment Group
Co., Ltd. | State-owned
corporation | 2.56% | 31,770,010 | 0 | | | Qinghai Puren
Intelligent
Technology R & D
Center (Limited
Partnership) | Domestic non-
state-owned
corporation | 2.15% | 26,628,340 | 0 | | | Qiu Yezhi | Domestic
individual | 1.88% | 23,382,388 | 23,382,388 | | | Hong Kong
Securities Clearing
Company Limited | Overseas
corporation | 1.27% | 15,712,884 | 0 | | | JIC Investment Co.,
Ltd. | State-owned
corporation | 0.72% | 8,884,216 | 0 | | | Shengji Equity
Investment Fund
(Shanghai) Co.,
Ltd. | State-owned
corporation | 0.58% | 7,198,000 | 0 | In pledge | 6,700,000 | Liu Wucai | Domestic
individual | 0.53% | 6,597,688 | 0 | | | Top 10 unrestricted ordinary shareholders | | | | | | | Name of shareholder | Unrestricted shares held at the period-end | Shares by type | | | | | | | Type | Shares | | | | Tang Zhuomian | 96,885,134 | RMB ordinary
shares | 96,885,134 | | | | Tang Zhuolin | 67,684,392 | RMB ordinary
shares | 67,684,392 | | | | Pulead Technology Industry Co.,
Ltd. | 48,149,787 | RMB ordinary
shares | 48,149,787 | | | | Luzhou Industrial Development
Investment Group Co., Ltd. | 31,770,010 | RMB ordinary
shares | 31,770,010 | | | | Qinghai Puren Intelligent
Technology R & D Center (Limited
Partnership) | 26,628,340 | RMB ordinary
shares | 26,628,340 | | | |
Hong Kong Securities Clearing
Company Limited | 15,712,884 | RMB ordinary
shares | 15,712,884 | JIC Investment Co., Ltd. | 8,884,216 | RMB ordinary
shares | 8,884,216 | Shengji Equity Investment Fund
(Shanghai) Co., Ltd. | 7,198,000 | RMB ordinary
shares | 7,198,000 | Liu Wucai | 6,597,688 | RMB ordinary
shares | 6,597,688 | Beixin Ruifeng Fund - ICBC -
Beijing Hengyutianze Investment
Management Co. | 6,171,777 | RMB ordinary
shares | 6,171,777 | Related or acting-in-concert parties
among the shareholders above | Tang Zhuolin and Tang Zhuomian are full brothers. On 18 August 2010, they signed the
Agreement on Acting in Concert.
Pulead Technology Industry Co., Ltd., and Qinghai Puren Intelligent Technology R & D
Center (Limited Partnership) are acting-in-concert parties.
Except for these, the Company does not know whether the other shareholders are related
parties or whether they are acting-in-concert parties in accordance with the Measures for
the Administration of acquisitions of listed companies. | | | Note on the top 10 shareholders'
participation in securities margin
trading (if any) | As of 31 March 2023, Pulead Technology Industry Co., Ltd., held 48,149,665 shares through
the credit securities account. And Luzhou Industrial Development Investment Group Co.,
Ltd., held 31,770,010 shares through the credit securities account, as well as Qinghai Puren
Intelligent Technology R & D Center (Limited Partnership) held 26,628,300 shares through
the credit securities account. | | |
Explanation on the shareholding of the repurchase account
As of the end of the Reporting Period, there were 36,424,192 shares in the Company’s special account for repurchase, accounting for
2.94% of its total share capital. As per the Shenzhen Stock Exchange Guideline No. 1 for the Self-regulation of Listed Companies—
Business Handling, the existence of a special account of repurchased shares among the top 10 shareholders should be specifically stated
but not included in the presentation of the top 10 shareholders. 2. Total Number of Preference Shareholders and Information of Top 10 Preference Shareholders □ Applicable √ Not applicable
III Other Significant Events
□Applicable √ Not applicable
IV Quarterly Financial Statements
1. Financial Statements
(1) Consolidated Balance Sheet
Prepared by: Guangdong Dongfang Precision Science & Technology Co., Ltd. 31 March 2023
Unit: RMB
Item | 31 March 2023 | 1 January 2023 | Current assets: | | | Cash and bank balances | 1,429,733,808.80 | 1,274,447,199.74 | Settlement provisions | | | Item | 31 March 2023 | 1 January 2023 | Dismantling funds | | | Financial assets held for trading | 826,564,639.52 | 860,832,278.88 | Derivative financial assets | | | Notes receivable | 25,771,245.44 | 24,566,100.12 | Accounts receivable | 765,635,440.37 | 837,305,757.46 | Receivable financing | 22,932,959.13 | 15,305,668.26 | Prepayments | 68,792,086.54 | 64,946,901.26 | Premium receivable | | | Receivable reinsurance account | | | Provision for reinsurance contract
receivable | | | Other receivables | 38,754,459.26 | 83,996,902.82 | Including: Interest receivable | | | Dividend receivable | | | Buy back resale financial assets | | | Inventories | 1,241,618,636.81 | 1,092,981,884.51 | Contract assets | 49,349,058.58 | 65,089,851.21 | Assets held for sale | | | Current portion of non-current
assets | 314,157,500.00 | 311,763,750.00 | Other current assets | 69,839,768.49 | 61,370,451.31 | Total current assets | 4,853,149,602.94 | 4,692,606,745.57 | Non-current assets: | | | Loans and advances | | | Debt investment | | | Other debt investments | | | Long-term receivables | 964,299.00 | 1,294,299.00 | Long-term equity investment | 93,752,046.01 | 95,352,681.52 | Investment in other equity
instruments | | | Other non-current financial assets | 334,959,677.33 | 334,449,603.33 | Real estate investment | | | Fixed assets | 565,867,646.04 | 570,200,113.79 | Construction in progress | 71,640,546.10 | 38,904,537.85 | Productive biological assets | | | Oil and gas asset | | | Right-of-use assets | 84,141,310.80 | 86,448,978.02 | Intangible assets | 363,731,709.22 | 368,103,395.11 | Development expenditure | 3,702,229.76 | 3,702,229.76 | Goodwill | 432,511,475.32 | 430,916,848.74 | Long-term prepaid expenses | 18,420,319.96 | 16,735,552.98 | Item | 31 March 2023 | 1 January 2023 | Deferred tax assets | 247,119,485.63 | 244,542,124.61 | Other non-current assets | 57,827,610.24 | 45,320,004.82 | Total non-current assets | 2,274,638,355.41 | 2,235,970,369.53 | Total assets | 7,127,787,958.35 | 6,928,577,115.10 | Current liabilities: | | | Short-term borrowings | 96,301,680.12 | 41,815,129.24 | Borrowing from the Central Bank | | | Borrowed funds | | | Financial liabilities held for trading | 57,027,528.33 | 57,022,555.58 | Derivative financial liabilities | | | Notes payable | 130,127,953.80 | 149,918,253.31 | Accounts payable | 703,414,660.38 | 748,319,561.21 | Advance receivables | | | Contract liabilities | 825,114,775.47 | 692,567,968.60 | Selling back financial assets | | | Deposits and Interbank deposit | | | Agent trading securities | | | Agent underwriting securities | | | Employee benefits payable | 126,518,352.61 | 123,695,328.31 | Tax payable | 34,356,429.92 | 24,111,703.70 | Other payables | 114,071,613.11 | 90,080,142.50 | Including: Interest payable | | | Dividend payable | | | Fees and commissions | | | Reinsurance accounts payable | | | Liabilities held for sale | | | Current portion of non-current
liabilities | 320,259,921.59 | 315,767,431.26 | Other current liabilities | 7,843,151.62 | 5,988,879.29 | Total current liabilities | 2,415,036,066.95 | 2,249,286,953.00 | Non-current liabilities: | | | Insurance contract reserve | | | Long-term borrowings | 56,452,115.15 | 57,884,494.89 | Bonds payable | | | Including: Preference Shares | | | Perpetual bonds | | | Lease liabilities | 61,528,268.38 | 68,989,111.33 | Long-term payables | | | Long-term employee benefits
payable | 12,896,110.14 | 13,179,944.17 | Provisions | 118,690,395.19 | 118,945,953.78 | Item | 31 March 2023 | 1 January 2023 | Deferred income | 10,794,486.66 | 11,073,651.66 | Deferred tax liabilities | 5,463,483.83 | 6,825,450.77 | Other non-current liabilities | 136,603,881.90 | 136,396,292.55 | Total non-current liabilities | 402,428,741.25 | 413,294,899.15 | Total Liabilities | 2,817,464,808.20 | 2,662,581,852.15 | Equity: | | | Share capital | 1,240,978,400.00 | 1,241,106,400.00 | Other equity instruments | | | Including: Preference Shares | | | Perpetual bonds | | | Capital surplus | 2,954,305,867.27 | 2,947,263,843.53 | Less: Treasury stock | 309,451,578.83 | 240,255,502.45 | Other comprehensive income | 35,430,564.25 | 26,512,917.07 | Special reserve | 15,779,321.40 | 14,488,955.52 | Surplus reserves | 51,830,974.45 | 51,830,974.45 | General risk preparation | | | Retained earnings | 107,992,065.03 | 23,018,722.11 | Total equity attributable to owners of the
parent | 4,096,865,613.57 | 4,063,966,310.23 | Non-controlling interests | 213,457,536.58 | 202,028,952.72 | Total equity | 4,310,323,150.15 | 4,265,995,262.95 | Total liabilities and equity | 7,127,787,958.35 | 6,928,577,115.10 |
(2) Consolidated Income Statement for Q1 2023
Unit: RMB
Item | Q1 2023 | Q1 2022 | 1 Total operating revenue | 907,101,141.80 | 636,006,580.11 | Including: Operating revenue | 907,101,141.80 | 636,006,580.11 | Interest income | | | Premiums earned | | | Fee and commission income | | | 2 Total operating cost | 816,570,578.44 | 576,816,779.91 | Including: Cost of sales | 653,454,327.84 | 472,346,527.10 | Interest expense | | | Payment of fees and commission | | | Surrender fund | | | Net indemnity expenditure | | | Draw the net reserve of insurance | | | Item | Q1 2023 | Q1 2022 | liability contract | | | Policy dividend expense | | | Reinsurance cost | | | Taxes and surcharges | 4,693,860.22 | 4,022,255.53 | Selling expenses | 49,395,917.66 | 24,373,541.29 | Administrative expenses | 76,467,070.01 | 62,766,418.15 | R&D expenses | 27,637,218.09 | 18,824,950.19 | Finance costs | 4,922,184.62 | -5,516,912.35 | Including: Interest expenses | 2,869,618.96 | 4,443,668.86 | Interest income | 6,504,802.55 | 5,483,896.31 | Add: Other income | 2,550,704.06 | 3,455,142.45 | Investment income (loss with "-" sign) | 11,843,626.19 | -4,249,447.63 | Including: Share of profit or loss of joint
ventures and associates | -1,617,104.92 | 44,614.18 | Income from derecognition of
financial assets measured at amortized cost (loss with
"-" sign) | | | Exchange gain (loss with "-" sign) | | | Net exposure hedging gain (loss with "-"
sign) | | | Gain/loss on changes in fair value (loss with
"-" sign) | 18,689,791.21 | -8,257,489.80 | Credit impairment loss (loss is listed with "-
" sign) | -410,038.39 | 4,297,826.65 | Asset impairment loss (loss with "-" sign) | -1,438,574.33 | -634,508.31 | Gain/loss on disposal of assets (loss with "-"
sign) | -382,067.42 | | 3 Operating profit (losses are listed with "-" sign) | 121,384,004.68 | 53,801,323.56 | Add: Non-operating income | 876,053.60 | 238,187.76 | Less: Non-operating expenses | 882,910.87 | 81,446.72 | 5 Gross profit (the gross loss shall be filled in with the
sign "-") | 121,377,147.41 | 53,958,064.60 | Less: Income tax expenses | 24,873,932.20 | 12,707,811.73 | Net profit (net loss is listed with "-" sign) | 96,503,215.21 | 41,250,252.87 | (1) Net profit from continuing operations | | | i. Net profit from continuing operations (net loss
with "-" sign) | 96,503,215.21 | 41,250,252.87 | ii. Net profit from termination of operation (net
loss with "-" sign) | | | (2) Net profit classified by attribution of
ownership | | | i. Net profit attributable to owners of the parent | 84,973,342.92 | 37,109,411.15 | Item | Q1 2023 | Q1 2022 | ii. Net profit attributable to non-controlling
interests | 11,529,872.29 | 4,140,841.72 | 6 Other comprehensive income/(loss), net of tax | 8,816,358.75 | -12,147,447.87 | Other comprehensive income/(loss) attributable
to owners of the parent, net of tax | 8,917,647.18 | -11,336,050.09 | (1) Other comprehensive loss that will not be
reclassified to profit or loss | -229,036.89 | 267,186.98 | i. Changes caused by remeasurements
on defined benefit schemes | -229,036.89 | 267,186.98 | ii. Other comprehensive income that
cannot be transferred to profit or loss under the equity
method | | | iii. Changes in fair value of investments
in other equity instruments | | | iv. Fair value change of enterprise's
own credit risk | | | v. Other | | | (2) Other comprehensive income/(loss) that
will be reclassified to profit or loss | 9,146,684.07 | -11,603,237.07 | i. Other comprehensive income that can
be transferred to profit or loss under the equity method | | | ii. Changes in fair value of other debt
investments | | | iii. The amount of financial assets
reclassified to other comprehensive income | | | iv. Provision for credit impairment of
other debt investments | | | v. Cash flow hedging reserve | | | vi. Differences arising from the
translation of foreign currency-denominated financial
statements | 9,146,684.07 | -11,603,237.07 | vii. Other | | | Other comprehensive income attributable to non-
controlling interests, net of tax | -101,288.43 | -811,397.78 | Total comprehensive income | 105,319,573.96 | 29,102,805.00 | Total comprehensive income attributable to
owners of the parent | 93,890,990.10 | 25,773,361.06 | Total comprehensive income attributable to non-
controlling interests | 11,428,583.86 | 3,329,443.94 | Earnings per share: | | | (1) Basic earnings per share | 0.07 | 0.03 | (2) Diluted earnings per share | 0.07 | 0.03 |
(3) Consolidated Statement of Cash Flows for Q1 2023 (未完)
|
|